Shanghai, China

Qingqian Meng


Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):

Title: Qingqian Meng: Innovator in Glycopeptide Compounds

Introduction

Qingqian Meng is a notable inventor based in Shanghai, China. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of glycopeptide compounds. His work focuses on combating drug-resistant bacteria, which is a growing concern in modern medicine.

Latest Patents

Qingqian Meng holds a patent for glycopeptide compounds that exhibit activity against drug-resistant bacteria. The patent details a preparation method and application for these compounds, which conform to a specific general formula. Testing has shown that these glycopeptide antibiotic compounds possess higher inhibition activity against drug-resistant strains, particularly MRSA and VRE, compared to the second-generation glycopeptide drug oritavancin. Furthermore, many of these compounds demonstrate a safety profile that exceeds that of oritavancin, making them suitable for developing drugs aimed at treating various bacterial infections, including skin and soft tissue infections, meningitis, sepsis, pneumonia, arthritis, peritonitis, bronchitis, and empyema.

Career Highlights

Throughout his career, Qingqian Meng has worked with prominent companies in the biopharmaceutical sector. He has been associated with Shanghai Laiyi Center for Biopharmaceutical R&D Co., Ltd. and Zhejiang Medicine Co., Ltd. His expertise in the field has allowed him to contribute to innovative solutions in combating bacterial infections.

Collaborations

Qingqian Meng has collaborated with several professionals in his field, including Chang Shao and Mei Ge. These collaborations have further enhanced his research and development efforts in glycopeptide compounds.

Conclusion

Qingqian Meng is a pioneering inventor whose work in glycopeptide compounds is making strides in the fight against drug-resistant bacteria. His contributions are vital in the ongoing battle against bacterial infections, showcasing the importance of innovation in the biopharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…